Literature DB >> 17950256

CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.

Clara Touriño1, Catherine Ledent, Rafael Maldonado, Olga Valverde.   

Abstract

BACKGROUND: 3,4-Methylenedioxymethamphetamine (MDMA) is a popular recreational drug widely abused by young people. The endocannabinoid system is involved in the addictive processes induced by different drugs of abuse. However, the role of this system in the pharmacological effects of MDMA has not yet been clarified.
METHODS: Locomotion, body temperature, and anxiogenic-like responses were evaluated after acute MDMA administration in CB(1) cannabinoid receptor 1 knockout mice. Additionally, MDMA rewarding properties were investigated in the place conditioning and the intravenous self-administration paradigms. Extracellular levels of dopamine (DA) in the nucleus accumbens were also analyzed after a single administration of MDMA by in vivo microdialysis.
RESULTS: Acute MDMA administration increased locomotor activity, body temperature, and anxiogenic-like responses in wild-type mice, but these responses were lower or abolished in knockout animals. 3,4-Methylenedioxymethamphetamine produced similar conditioned place preference and increased dopamine extracellular levels in the nucleus accumbens in both genotypes. Nevertheless, CB(1) knockout mice failed to self-administer MDMA at any of the doses used.
CONCLUSIONS: These results indicate that CB(1) cannabinoid receptors play an important role in the acute prototypical effects of MDMA and are essential in the acquisition of an operant behavior to self-administer this drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950256     DOI: 10.1016/j.biopsych.2007.09.003

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  A single episode of maternal deprivation impairs the motivation for cocaine in adolescent mice.

Authors:  Mariangela Martini; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2011-06-25       Impact factor: 4.530

2.  Quantitative arbor analytics: unsupervised harmonic co-clustering of populations of brain cell arbors based on L-measure.

Authors:  Yanbin Lu; Lawrence Carin; Ronald Coifman; William Shain; Badrinath Roysam
Journal:  Neuroinformatics       Date:  2015-01

3.  The orphan receptor GPR3 modulates the early phases of cocaine reinforcement.

Authors:  Clara Tourino; Emmanuel Valjent; Jessica Ruiz-Medina; Denis Herve; Catherine Ledent; Olga Valverde
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

4.  Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice.

Authors:  Clara Ros-Simó; Jessica Ruiz-Medina; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2011-12-06       Impact factor: 4.530

5.  Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.

Authors:  Carmen Manzanedo; Marta Rodríguez-Arias; Manuel Daza-Losada; Concepción Maldonado; María A Aguilar; José Miñarro
Journal:  Behav Brain Funct       Date:  2010-03-22       Impact factor: 3.759

6.  THC Prevents MDMA Neurotoxicity in Mice.

Authors:  Clara Touriño; Andreas Zimmer; Olga Valverde
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 7.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

Review 8.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

9.  A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).

Authors:  Yoko Nawata; Takato Hiranita; Tsuneyuki Yamamoto
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.